Spotlight
Video

The Erlotinib/Bevacizumab Combination in EGFR Mutation-Positive Advanced NSCLC: Is Progression-Free Survival without Overall Survival Benefit Enough? (BMIC-043)

BeaconMedIC has 73 videos Subscribe Here

Loading........
Description: Dr. Jack West discusses results and the significance of two important Japanese trials that test the combination of erlotinib (Tarceva) with bevacizumab (Avastin), which shows a consistent improvement in progression-free survival but not overall survival.
Shared By : BeaconMedIC
Posted on : 07/01/18
Added : 1 year ago